Large-scale imatinib dose–concentration–effect study in CML patients under routine care conditions-Reference-Cited by-同舟云学术

Large-scale imatinib dose–concentration–effect study in CML patients under routine care conditions

Published:2014-07 Issue:7 Volume:38 Page:764-772
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Gotta Verena,Bouchet Stephane,Widmer Nicolas,Schuld Peter,Decosterd Laurent A.,Buclin Thierry,Mahon Francois-Xavier,Csajka Chantal,Molimard Mathieu

Funder

Novartis Pharma Schweiz

Swiss National Science Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference41 articles.

1. Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia;Hochhaus;Leukemia,2009

2. International randomized study of interferon vs STI571 (IRIS) 8-year follow up: sustained survival and low risk for progression or events in patients with newly diagnosed chronic myeloid leukemia in chronic phase (CML-CP) treated with imatinib;Deininger;ASH Annu Meet Abstr,2009

3. Evolving treatment strategies for patients newly diagnosed with chronic myeloid leukemia: the role of second-generation BCR-ABL inhibitors as first-line therapy;Shami;Leukemia,2012

4. Managing resistance in chronic myeloid leukemia;Roychowdhury;Blood Rev,2011

5. Pharmacokinetic/pharmacodynamic correlation and blood-level testing in imatinib therapy for chronic myeloid leukemia;Cortes;Leukemia,2009

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Constitutional DNA Polymorphisms Associated with the Plasma Imatinib Concentration in Chronic Myeloid Leukemia Patients;Pharmaceutics;2024-06-19

2. Therapeutic drug monitoring of osimertinib in EGFR mutant non‐small cell lung cancer by dried blood spot and plasma collection: A pilot study;British Journal of Clinical Pharmacology;2024-05-05

3. Predictive performance of population pharmacokinetic models of imatinib in chronic myeloid leukemia patients;Cancer Chemotherapy and Pharmacology;2024-03-05

4. Population pharmacokinetics and pharmacogenetics analyses of imatinib in Chinese patients with chronic myeloid leukemia in a real-world situation;Cancer Chemotherapy and Pharmacology;2023-08-25

5. Imatinib Analogs in Chronic Myeloid Leukemia: a Systematic Qualitative Review;Current Pharmacology Reports;2023-04-10